DelveInsight Business Research LLP
DelveInsight’s “Radiodermatitis Market Insights, Epidemiology, and Market Forecast-2032” report provides an in-depth understanding of radiodermatitis, historical and forecast epidemiology, and radiodermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight has launched a new report on “Radiodermatitis – Market Overview, Epidemiology and Market Forecast-2030”.
by DelveInsight “Radiodermatitis – Market Overview, Epidemiology and Market Forecast-2030″ The report provides an in-depth understanding of radiodermatitis, historical and forecast epidemiology as well as radiodermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and the Japan.
Some of the key facts from the Radiodermatitis Market report:
According to a study by Singh M et al. titled “Radiodermatitis: A Review of Our Current Understanding,” approximately 95% of cancer patients receiving radiation therapy will develop some form of radiodermatitis, including erythema, dry scaling, and wet scaling.
“Prevention and treatment of acute and chronic radiodermatitis” by Seite S et al. clarified that the Symptoms of acute radiodermatitis have been classified into three levels; grade 1 (mild erythema), grade 2 (dry desquamation) and grade 3 (severe moist desquamation). Grade 1 skin toxicity remains a problem for approximately 90% of patients and Grade 2 for 30% of patients.
Key benefits of the report:
The Radiodermatitis Market report covers descriptive overview and comprehensive overview of the Radiodermatitis and Radiodermatitis Epidemiology Market in 7MM (US, EU5 (Germany, Spain, France, Italy, UK ) and Japan.)
The Radiodermatitis Market report provides information on current and emerging therapies.
The Radiodermatitis Market report provides historical and forecast global market covering the diffusion of drugs in 7MM.
The Radiodermatitis Market report provides an advantage which will help in developing business strategies by understanding the trends shaping and driving the Radiodermatitis market.
You have questions ? Click here to learn more about the radiodermatitis market landscape.
Overview of Radiodermatitis
Radiation dermatitis, also known as radiation dermatitis, x-ray dermatitis, radiation skin damage, or radiation burn, is a condition that primarily affects the skin followed by exposure to radiation therapy. It is essentially described as a side effect of radiotherapy. The development and severity of radiation dermatitis is associated with multiple patient and treatment factors, such as total radiation dose, duration of radiation therapy, and chemotherapy treatment.
The dynamics of Radiodermatitis Market is expected to change in the coming years due to the expected launch of emerging therapies such as Reata Pharmaceuticals, Inc., Noveome Biotherapeutics and others during the forecast period 2018-2030.
Radiodermatitis Pipeline Therapies and Key Companies
Omaveloxolone Lotion: Reata Pharmaceuticals, Inc.
Biological: ST266: Noveome Biotherapeutics
1. Presentation of the report
2. Executive Summary
3. SWOT Analysis
4. Share of Radiodermatitis Patients (%) Overview at a Glance
5. Radiodermatitis Market Overview at a Glance
6. Background and overview of radiodermatitis
7. Radiation dermatitis epidemiology and patient population
8. Radiodermatitis Patient Population by Countries
9. Current Radiation Dermatitis Treatment and Medical Practices
10. Unmet Needs
11. Emerging therapies for radiodermatitis
12. Radiodermatitis Market Outlook
13. Radiodermatitis Market Analysis by Countries (2018-2030)
14. Market Access and Reimbursement of Therapies
15. Market Drivers
16. Market Barriers
18. Radiation Dermatitis Reporting Methodology
19. DelveInsight Abilities
21. About DelveInsight
DelveInsight’s “Radiodermatitis Pipeline Insight, 2021” report presents comprehensive insights into the current clinical development scenarios and growth prospects in the radiodermatitis market. A detailed picture of the Radiodermatitis pipeline landscape is provided, which includes the disease overview and Radiodermatitis treatment guidelines.
Epidemiology of radiodermatitis
DelveInsight’s “Radiodermatitis Epidemiology Forecast to 2030” report provides an in-depth understanding of the disease, historical and predicted epidemiology of radiodermatitis in the 7MM i.e. US, EU5 (Germany , Spain, Italy, France and the United Kingdom), and Japan.
Company Name: DelveInsight Business Research LLP
Contact: Kritika Rehani
E-mail: Send an email
Address:304 S. Jones Boulevard #2432
Country: United States